Regulus Therapeutics Inc. Annual Interest Expense in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
Regulus Therapeutics Inc. quarterly/annual Interest Expense history and growth rate from 2010 to 2023.
  • Regulus Therapeutics Inc. Interest Expense for the quarter ending March 31, 2024 was $81K, a 56.2% decline year-over-year.
  • Regulus Therapeutics Inc. Interest Expense for the twelve months ending March 31, 2024 was $500K, a 30.4% decline year-over-year.
  • Regulus Therapeutics Inc. annual Interest Expense for 2023 was $604K, a 12.2% decline from 2022.
  • Regulus Therapeutics Inc. annual Interest Expense for 2022 was $688K, a 19.5% decline from 2021.
  • Regulus Therapeutics Inc. annual Interest Expense for 2021 was $855K, a 52.7% decline from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $604K -$84K -12.2% Jan 1, 2023 Dec 31, 2023 10-K 2024-03-21
2022 $688K -$167K -19.5% Jan 1, 2022 Dec 31, 2022 10-K 2024-03-21
2021 $855K -$953K -52.7% Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $1.81M -$323K -15.2% Jan 1, 2020 Dec 31, 2020 10-K 2022-03-11
2019 $2.13M -$212K -9.05% Jan 1, 2019 Dec 31, 2019 10-K 2021-03-09
2018 $2.34M -$380K -14% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-12
2017 $2.72M +$1.54M +130% Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
2016 $1.18M +$1.13M +2173% Jan 1, 2016 Dec 31, 2016 10-K 2019-03-18
2015 $52K +$13K +33.3% Jan 1, 2015 Dec 31, 2015 10-K 2018-03-08
2014 $39K +$3K +8.33% Jan 1, 2014 Dec 31, 2014 10-K 2017-03-03
2013 $36K -$211K -85.4% Jan 1, 2013 Dec 31, 2013 10-K 2016-02-23
2012 $247K -$141K -36.3% Jan 1, 2012 Dec 31, 2012 10-K 2015-02-19
2011 $388K +$26K +7.18% Jan 1, 2011 Dec 31, 2011 10-K 2014-02-28
2010 $362K Jan 1, 2010 Dec 31, 2010 10-K 2013-02-19
* An asterisk sign (*) next to the value indicates that the value is likely invalid.